Generic Sweden AB provides consulting and telecommunication services in Sweden. More Details
Flawless balance sheet with solid track record.
Share Price & News
How has Generic Sweden's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: GENI is more volatile than 90% of Swedish stocks over the past 3 months, typically moving +/- 15% a week.
Volatility Over Time: GENI's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
7 Day Return
1 Year Return
Return vs Industry: GENI exceeded the Swedish IT industry which returned 27.6% over the past year.
Return vs Market: GENI exceeded the Swedish Market which returned 17.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Generic Sweden's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 days ago | Simply Wall StDoes Generic Sweden AB (STO:GENI) Have A Place In Your Dividend Portfolio?
3 weeks ago | Simply Wall StIs Now The Time To Look At Buying Generic Sweden AB (STO:GENI)?
1 month ago | Simply Wall StIs Generic Sweden AB's (STO:GENI) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Is Generic Sweden undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: GENI (SEK47.5) is trading above our estimate of fair value (SEK23.56)
Significantly Below Fair Value: GENI is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: GENI is poor value based on its PE Ratio (59.4x) compared to the SE IT industry average (26.4x).
PE vs Market: GENI is poor value based on its PE Ratio (59.4x) compared to the Swedish market (22.8x).
Price to Earnings Growth Ratio
PEG Ratio: GENI is poor value based on its PEG Ratio (3.4x)
Price to Book Ratio
PB vs Industry: GENI is overvalued based on its PB Ratio (36.4x) compared to the SE IT industry average (3.8x).
How is Generic Sweden forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GENI's forecast earnings growth (17.7% per year) is above the savings rate (0.5%).
Earnings vs Market: GENI's earnings (17.7% per year) are forecast to grow faster than the Swedish market (11.6% per year).
High Growth Earnings: GENI's earnings are forecast to grow, but not significantly.
Revenue vs Market: GENI's revenue (13% per year) is forecast to grow faster than the Swedish market (3.4% per year).
High Growth Revenue: GENI's revenue (13% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GENI's Return on Equity is forecast to be very high in 3 years time (45.4%).
How has Generic Sweden performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GENI has a high level of non-cash earnings.
Growing Profit Margin: GENI's current net profit margins (13.1%) are higher than last year (11.6%).
Past Earnings Growth Analysis
Earnings Trend: GENI's earnings have grown significantly by 20.2% per year over the past 5 years.
Accelerating Growth: GENI's earnings growth over the past year (32.3%) exceeds its 5-year average (20.2% per year).
Earnings vs Industry: GENI earnings growth over the past year (32.3%) exceeded the IT industry 7.7%.
Return on Equity
High ROE: GENI's Return on Equity (61.4%) is considered outstanding.
How is Generic Sweden's financial position?
Financial Position Analysis
Short Term Liabilities: GENI's short term assets (SEK30.6M) exceed its short term liabilities (SEK12.3M).
Long Term Liabilities: GENI's short term assets (SEK30.6M) exceed its long term liabilities (SEK6.1M).
Debt to Equity History and Analysis
Debt Level: GENI is debt free.
Reducing Debt: GENI has not had any debt for past 5 years.
Debt Coverage: GENI has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: GENI has no debt, therefore coverage of interest payments is not a concern.
What is Generic Sweden current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: GENI's dividend (0.63%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (1.19%).
High Dividend: GENI's dividend (0.63%) is low compared to the top 25% of dividend payers in the Swedish market (3.76%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, GENI has been paying a dividend for less than 10 years.
Growing Dividend: GENI has only been paying a dividend for 5 years, and since then payments have not increased.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (37.5%), GENI's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: GENI's dividends in 3 years are forecast to be covered by earnings (84.1% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Jonas Jegerborn (48 yo)
Mr. Jonas Jegerborn serves as a Chief Executive Officer and President at Generic Sweden AB.
CEO Compensation Analysis
Compensation vs Market: Jonas's total compensation ($USD271.60K) is about average for companies of similar size in the Swedish market ($USD235.13K).
Compensation vs Earnings: Insufficient data to compare Jonas's compensation with company performance.
|Owner & Member of the board||11yrs||kr75.00k||no data|
|Independent Director||11.5yrs||kr75.00k||no data|
|Chairman of the Board||11yrs||kr150.00k||no data|
|Independent Director||6.5yrs||kr75.00k||no data|
Experienced Board: GENI's board of directors are seasoned and experienced ( 11 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Generic Sweden AB's company bio, employee growth, exchange listings and data sources
- Name: Generic Sweden AB
- Ticker: GENI
- Exchange: OM
- Founded: 1993
- Industry: IT Consulting and Other Services
- Sector: Software
- Market Cap: kr534.703m
- Shares outstanding: 12.29m
- Website: https://www.generic.se
Number of Employees
- Generic Sweden AB
- Hangovagen 18
- Stockholm County
- 115 41
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|GENI||OM (OMX Nordic Exchange Stockholm)||Yes||Common Shares||SE||SEK||Jan 2007|
Generic Sweden AB provides consulting and telecommunication services in Sweden. The company’s Consultancy division offers high-quality services to clients within the defense and civil security sector, as w...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/11/27 18:40|
|End of Day Share Price||2020/11/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.